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Bacterial infection is associated with increasedmorbidity in patients with systematic lupus erythematosus. In
a recent Immunity paper, Gallo et al. (2015) report that extracellular DNA is bound tightly by bacterial amyloid
fibrils during biofilm formation and that amyloid/DNA composites are immune stimulators when injected into
mice, leading to autoimmunity.Amyloid proteins, which are characterized
by the formation of a highly organized
cross-b sheet quaternary structure, are
primarily linked with neurodegenerative
diseases, including Alzheimer’s disease,
Parkinson’s disease, and prion diseases.
Thesediseasesareassociatedwithprotein
misfolding and amyloid fiber formation,
which can be cytotoxic and contribute to
the disease state. However, not all amyloid
fibers are a detriment to the organism that
produces them. Some bacterial species
produce so-called ‘‘functional’’ amyloids
that perform physiological roles that ulti-
mately benefit the organism. One such
example is curli, an extracellular amyloid
produced by Escherichia coli and Salmo-
nella typhimurium. Curli amyloid fibers are
the major proteinaceous component of
the extracellular matrix (ECM), which is
required for floating pellicle biofilm forma-
tion. The main curli subunit protein, CsgA,
is transported to the cell surface and poly-
merized into an amyloid fiber by the corre-
sponding csgBAC and csgDEFG operons
(Evans and Chapman, 2014). In addition
to their role in biofilm formation, curli fibrils
contribute to bacterial pathogenesis dur-
ing numerous infections, including urinary
tract infections and sepsis (Kai-Larsen
et al., 2010; Cegelski et al., 2009).
Mammalian amyloids have been shown
to be capable of inducing autoimmunity
when complexed with cofactors such as
host DNA (Di Domizio et al., 2012b). Auto-
immunity describes abnormal circum-
stances where the host immune system
erroneously identifies normal host-derived
substances or tissues as invading foreign
matter, ultimately resulting in self-inflicted
damage to the host. This improper anti-self response may be restricted to certain
organs, such as is the case with autoim-
mune thyroiditis, may target a specific
type of tissue that is present throughout
the body, as occurs in Goodpasture syn-
drome, or may result in the breakdown of
tolerance to nuclear antigens, which is
observed in patients with systematic lupus
erythematosus (lupus). Environmental co-
factors, such as DNA, RNA, or glyocloami-
noglycans, promote the conversion of
mammalian amyloid precursor proteins
into insoluble amyloid fibrils by binding to
the precursor proteins and increasing the
rate of amyloid polymerization (Di Domizio
et al., 2012a). Amyloid/DNA complexes
are recognized and phagocytosed by
circulating plasmacytoid dendritic cells
(pDCs) (Di Domizio et al., 2012b). Like
other debris taken up by pDCs, the amy-
loid/DNA complex enters the endocytic
compartment for processing and eventual
degradation. However, in some cases,
amyloid fibrils are able to attach to recep-
tors present on the cell membrane, thus
preventing the shuttling of the complex to
the lysosome for degradation (Di Domizio
et al., 2012b). The retention of the amy-
loid/DNA complex in the early endosome
triggers the intracellular DNA sensor,
toll-like receptor (TLR) 9, stimulating an
immune cascade that results in the tran-
scription of type 1 IFNs and, eventually,
the production of antinuclear antibodies,
which can lead to autoimmune diseases
like lupus (Di Domizio et al., 2012b). Deple-
tion of pDCs inmice injected with amyloid/
DNA complex abolished type 1 IFN pro-
duction and dramatically reduced the
number of antinuclear antibodies (Di Do-
mizio et al., 2012b).Cell Host & MicThe ability of mammalian amyloid/DNA
complexes to stimulate autoimmunity led
Gallo et al. (2015) to postulate that func-
tional amyloids, like curli, may also be
able to stimulate a lupus-like autoimmunity
within a host. A link between bacterial
infection and autoimmunity is supported
by the clinical observations that bacterial
infections often trigger disease flairs and
represent a major cause of morbidity and
mortality in patients with lupus (Petri,
1998). Further support for the hypoth-
esis that amyloid/DNA composites are
involved in triggering autoimmunity is the
fact that one of themajor infectious agents
associated with morbidity in patients with
lupus is the curli-producing organism Sal-
monella. Also, it has been reported that
curli are recognized by the host immune
system through interactions with TLR2/
TLR-1 heterocomplex (Tu¨kel et al., 2010).
This interaction between curli and the
TLR1/2 heterocomplex is thought to rein-
force gut membrane permeability, sug-
gesting a tissue- or cell-specific response
to the amyloid proteins. Using a
S. typhimurium strain whose curli pro-
moter drives expression of GFP, Gallo
et al. (2015) were able to demonstrate
that themajority of bacteriawithin a biofilm
expresscurli. Furthermore, theauthorsde-
tected extracellular DNA (eDNA) in these
biofilms that was intimately associated
with the curli amyloid fibers. Like DNA
bound to mammalian amyloid fibrils,
eDNA bound to curli was resistant to
DNase treatment and was retained in the
curli fibrils even after the curli was purified
from the biofilm. Therefore, eDNA that had
been incorporated into the biofilm was
protected from cellular degradation.robe 18, July 8, 2015 ª2015 Elsevier Inc. 1
Figure 1. Schematic Overview of Autoimmunity Stimulated by Bacterial Amyloid Biofilm
Formation
eDNA is integrated into the curli biofilm formed by Salmonella typhimurium, increasing the rate of amyloid
polymerization and biofilm formation. Subsequently, dendritic cells (DCs) can recognize and phagocytose
curli/eDNA composites, stimulating an immunogenic response that leads to the induction of inflammatory
cytokines and the production of antinuclear antibodies. The presence of antinuclear antibodies can lead to
autoimmune diseases, like lupus.
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PreviewsThe formation of biofilms is a defining
step for many bacterial invaders as it pro-
vides protection from the mounting im-
mune response. Gallo et al. (2015) showed
that the addition of DNA to unpolymerized
curli subunits resulted in rapid curli poly-
merization, indicating that the incorpora-
tion of DNA in vivo likely increases the
rate of biofilm formation. However, bacte-
ria within a biofilm were not completely
protected from the immune response as
conventional dendritic cells (cDCs) incu-
bated with the Salmonella biofilms were
seen to send dendrites into the biofilm
community and phagocytose bacteria
and eDNA (Figure 1). Interestingly, ex-
posing cDCs isolated from lupus-prone
mice to curli/DNA composites stimulated
high levels of pro-inflammatory cytokines,
including IL-6, IL-12 indicating the potent
immunogenicity of the curli/DNA compos-
ites. Curli/DNA composites also resulted
in the production of type 1 IFNs and IFN-
stimulated genes in exposed cDCs. Injec-
tion of young lupus-prone and non-lupus
prone mice with curli/DNA composites
resulted in the induction of anti-DNA
and anti-chromatin antinuclear antibodies,
with mice testing positive for anti-dsDNA2 Cell Host & Microbe 18, July 8, 2015 ª2015antibodies within 2 weeks of the initial in-
jection. Themajority of inducedantinuclear
antibodieswere of immunoglobulin G (IgG)
subclass 2a and 2b, which represent the
two antibody subclasses generally associ-
ated with systemic autoimmunity in pa-
tients (Clyneset al., 1998). Further,mice in-
jected with the curli/DNA complex tested
positive for lupus while mock-treated
mice of the same age did not, indicating
that exposure to curli/DNA complexes
can stimulate or exacerbate lupus in mice.
The discovery by Gallo et al. (2015) that
the curli/DNA complexes from the intesti-
nal pathogenS. typhimurium can influence
the development or progression of lupus in
their mouse model has significant implica-
tions because it raises the possibility that
an infection could play a role in initiating
or exacerbating autoimmunity (Figure 1).
However, the mechanism by which auto-
immunity is induced is largely unknown,
though it may mirror what occurs during
uptake of mammalian amyloid/DNA com-
plexes by pDCs (Di Domizio et al., 2012b).
In a more general sense, this study pro-
vokes questions regarding a potential role
for curli-expressingmembersof thegutmi-
crobiota, like E. coli, to influence gastroin-Elsevier Inc.testinal inflammation. E. coli is a small but
prevalent component of the healthy human
gut microbiota that undergoes significant
population expansion during periods of in-
testinal disorder (Kotlowski et al., 2007). If
curli-producing E. coli strains are able to
integrate eDNA into their curli biofilms
in vivo, then these organisms might also
be capable of stimulating inflammation
and/or anti-self antibodies, similar to what
the authors have shown occurs during
S. typhimurium infection. Humans harbor
trillions of microbes as part of their gastro-
intestinal microbiota. The complex func-
tion of these communities in promoting
human health and the consequences of
disease when the microbiota becomes
dysbiotic are the subject of intense re-
search. Unraveling the intersection of
bacterial amyloid production, DNA secre-
tion, and host susceptibility to inflamma-
tion and autoimmune disease will un-
doubtedly provide fascinating insights
into mechanisms by which the host pre-
vents inappropriate anti-self immune re-
sponses and the basis for a mechanism
by which commensal bacteria influence
inflammationandautoimmunity in thehost.
REFERENCES
Cegelski, L., Pinkner, J.S., Hammer, N.D., Cusu-
mano, C.K., Hung, C.S., Chorell, E., Aberg, V.,
Walker, J.N., Seed, P.C., Almqvist, F., et al.
(2009). Nat. Chem. Biol. 5, 913–919.
Clynes, R., Dumitru, C., and Ravetch, J.V. (1998).
Science 279, 1052–1054.
Di Domizio, J., Dorta-Estremera, S., Gagea, M.,
Ganguly, D., Meller, S., Li, P., Zhao, B., Tan, F.K.,
Bi, L., Gilliet, M., and Cao, W. (2012a). Proc. Natl.
Acad. Sci. USA 109, 14550–14555.
Di Domizio, J., Zhang, R., Stagg, L.J., Gagea, M.,
Zhuo, M., Ladbury, J.E., and Cao, W. (2012b).
J. Biol. Chem. 287, 736–747.
Evans, M.L., and Chapman, M.R. (2014). Biochim.
Biophys. Acta 1843, 1551–1558.
Gallo, P.M., Rapsinski, G.J., Wilson, R.P., Oppong,
G.O., Sriram, U., Goulian, M., Buttaro, B., Caric-
chio, R., Gallucci, S., and Tu¨kel, C¸. (2015). Immu-
nity 42, 1171–1184.
Kai-Larsen, Y., Lu¨thje, P., Chromek, M., Peters, V.,
Wang, X., Holm, A., Ka´das, L., Hedlund, K.O., Jo-
hansson, J., Chapman, M.R., et al. (2010). PLoS
Pathog. 6, e1001010.
Kotlowski, R., Bernstein, C.N., Sepehri, S., and
Krause, D.O. (2007). Gut 56, 669–675.
Petri, M. (1998). Rheum. Dis. Clin. North Am. 24,
423–456.
Tu¨kel, C., Nishimori, J.H., Wilson, R.P., Winter,
M.G., Keestra, A.M., van Putten, J.P., and Ba¨um-
ler, A.J. (2010). Cell. Microbiol. 12, 1495–1505.
